{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:07:19Z","timestamp":1785427639830,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010883","name":"Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["20241248"],"award-info":[{"award-number":["20241248"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010842","name":"Guangzhou Municipal Health Commission","doi-asserted-by":"publisher","award":["20201A011116"],"award-info":[{"award-number":["20201A011116"]}],"id":[{"id":"10.13039\/501100010842","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.intimp.2023.111429","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T12:35:00Z","timestamp":1704198900000},"page":"111429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1912-0615","authenticated-orcid":false,"given":"Xueying","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiesi","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6334-4685","authenticated-orcid":false,"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.intimp.2023.111429_b0005","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis[J]","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.intimp.2023.111429_b0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies[J]","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.intimp.2023.111429_b0015","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/hep.29845","article-title":"Time to step-up the fight against NAFLD[J]","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2023.111429_b0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.gastro.2016.06.022","article-title":"Loss of junctional adhesion molecule a promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol[J]","volume":"151","author":"Rahman","year":"2016","journal-title":"Gastroenterology"},{"issue":"129","key":"10.1016\/j.intimp.2023.111429_b0025","first-page":"136","article-title":"Expression of intestinal tight junction proteins in patients with non-alcoholic fatty liver disease[J]","volume":"61","author":"Xin","year":"2014","journal-title":"Hepatogastroenterology"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2023.111429_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/pr.2014.157","article-title":"Gut microbiome and nonalcoholic fatty liver diseases[J]","volume":"77","author":"Zhu","year":"2015","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.intimp.2023.111429_b0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells[J]","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"issue":"7384","key":"10.1016\/j.intimp.2023.111429_b0040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity[J]","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.intimp.2023.111429_b0045","article-title":"Green tea and epigallocatechin gallate (EGCG) for the management of nonalcoholic fatty liver diseases (NAFLD): Insights into the role of oxidative stress and antioxidant mechanism[J]","volume":"10","author":"Tang","year":"2021","journal-title":"Antioxidants (basel)"},{"issue":"5","key":"10.1016\/j.intimp.2023.111429_b0050","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders[J]","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.intimp.2023.111429_b0055","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/db14-1213","article-title":"Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARgamma-dependent switch from lipogenesis to fat oxidation[J]","volume":"64","author":"den Besten","year":"2015","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.intimp.2023.111429_b0060","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1111\/liv.14204","article-title":"Efficacy and safety of magnesium isoglycyrrhizinate injection in patients with acute drug-induced liver injury: A phase II trial[J]","volume":"39","author":"Wang","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.intimp.2023.111429_b0065","first-page":"2020","article-title":"Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin-induced model of liver injury[J]","volume":"42","author":"Zou","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.intimp.2023.111429_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173314","article-title":"Magnesium isoglycyrrhizinate alleviates fructose-induced liver oxidative stress and inflammatory injury through suppressing NOXs[J]","volume":"883","author":"Yang","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.intimp.2023.111429_b0075","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2019.00119","article-title":"Protective effects of magnesium glycyrrhizinate on methotrexate-induced hepatotoxicity and intestinal toxicity may be by reducing COX-2[J]","volume":"10","author":"Cao","year":"2019","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.intimp.2023.111429_b0080","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1080\/08923973.2018.1441300","article-title":"Magnesium isoglycyrrhizinate attenuates D-galactosamine\/lipopolysaccharides induced acute liver injury of rat via regulation of the p38-MAPK and NF-kappaB signaling pathways[J]","volume":"40","author":"Wang","year":"2018","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"10.1016\/j.intimp.2023.111429_b0085","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.bmc.2018.12.033","article-title":"Magnesium isoglycyrrhizinate suppresses LPS-induced inflammation and oxidative stress through inhibiting NF-kappaB and MAPK pathways in RAW264.7 cells[J]","volume":"27","author":"Xie","year":"2019","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"10.1016\/j.intimp.2023.111429_b0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000235873","article-title":"Prevention of free fatty acid-induced hepatic lipotoxicity in HepG2 cells by magnesium isoglycyrrhizinate in vitro[J]","volume":"84","author":"Cheng","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.intimp.2023.111429_b0095","doi-asserted-by":"crossref","first-page":"1022172","DOI":"10.3389\/fphar.2022.1022172","article-title":"High-fat diet combined with dextran sulfate sodium failed to induce a more serious NASH phenotype than high-fat diet alone[J]","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.intimp.2023.111429_b0100","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1046\/j.1440-1746.2003.03198.x","article-title":"Rodent nutritional model of non-alcoholic steatohepatitis: Species, strain and sex difference studies[J]","volume":"18","author":"Kirsch","year":"2003","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111429_b0105","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis[J]","volume":"69","author":"Cooper","year":"1993","journal-title":"Lab Invest"},{"issue":"6","key":"10.1016\/j.intimp.2023.111429_b0110","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease[J]","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2023.111429_b0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2249.1999.00878.x","article-title":"Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice[J]","volume":"116","author":"Obermeier","year":"1999","journal-title":"Clin Exp Immunol"},{"issue":"13","key":"10.1016\/j.intimp.2023.111429_b0120","doi-asserted-by":"crossref","first-page":"7201","DOI":"10.1111\/jcmm.15230","article-title":"Magnesium isoglycyrrhizinate prevents the nonalcoholic hepatic steatosis via regulating energy homeostasis[J]","volume":"24","author":"Jiang","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.intimp.2023.111429_b0125","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrd.2015.3","article-title":"Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies[J]","volume":"15","author":"Musso","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.intimp.2023.111429_b0130","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders[J]","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.intimp.2023.111429_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107194","article-title":"Improvement of magnesium isoglycyrrhizinate on DSS-induced acute and chronic colitis[J]","volume":"90","author":"Cui","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.intimp.2023.111429_b0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00394-019-01938-1","article-title":"Beneficial effects of ginger on prevention of obesity through modulation of gut microbiota in mice[J]","volume":"59","author":"Wang","year":"2020","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.intimp.2023.111429_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.900381","article-title":"Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease[J]","volume":"9","author":"Lu","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.intimp.2023.111429_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/biom12010056","article-title":"Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives[J]","volume":"12","author":"Vallianou","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.intimp.2023.111429_b0155","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41419-017-0124-2","article-title":"Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease[J]","volume":"9","author":"Sartini","year":"2018","journal-title":"Cell Death Dis"},{"issue":"9","key":"10.1016\/j.intimp.2023.111429_b0160","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ibd.20160","article-title":"Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients[J]","volume":"13","author":"Gisbert","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.intimp.2023.111429_b0165","doi-asserted-by":"crossref","first-page":"G518","DOI":"10.1152\/ajpgi.00024.2006","article-title":"Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis[J]","volume":"292","author":"Brun","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"21","key":"10.1016\/j.intimp.2023.111429_b0170","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.3748\/wjg.v18.i21.2609","article-title":"Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis[J]","volume":"18","author":"Ilan","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.intimp.2023.111429_b0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy[J]","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.intimp.2023.111429_b0180","article-title":"Modulation of gut microbiota by magnesium isoglycyrrhizinate mediates enhancement of intestinal barrier function and amelioration of methotrexate-induced liver injury[J]","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol"},{"issue":"19","key":"10.1016\/j.intimp.2023.111429_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/nu14194180","article-title":"Ethanol extract of licorice alleviates HFD-induced liver fat accumulation in association with modulation of gut microbiota and intestinal metabolites in obesity mice[J]","volume":"14","author":"Liu","year":"2022","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.intimp.2023.111429_b0190","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1124\/dmd.118.082008","article-title":"Glycyrrhizin alleviates nonalcoholic steatohepatitis via modulating bile acids and meta-inflammation[J]","volume":"46","author":"Yan","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.intimp.2023.111429_b0195","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41401-018-0110-y","article-title":"18beta-Glycyrrhetinic acid protects against alpha-naphthylisothiocyanate-induced cholestasis through activation of the Sirt1\/FXR signaling pathway[J]","volume":"39","author":"Wu","year":"2018","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.intimp.2023.111429_b0200","article-title":"Role of oxidative stress in the pathogenesis of non-alcoholic fatty liver disease: implications for prevention and therapy[J]","volume":"10","author":"Arroyave-Ospina","year":"2021","journal-title":"Antioxidants (basel)"},{"key":"10.1016\/j.intimp.2023.111429_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans[J]","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.intimp.2023.111429_b0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of Nonalcoholic Fatty Liver Disease\/Nonalcoholic Steatohepatitis[J]","volume":"22","author":"Manne","year":"2018","journal-title":"Clin Liver Dis"},{"issue":"3","key":"10.1016\/j.intimp.2023.111429_b0215","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.3892\/mmr.2017.6993","article-title":"Magnesium isoglycyrrhizinate protects against renal-ischemia-reperfusion injury in a rat model via anti-inflammation, anti-oxidation and anti-apoptosis[J]","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol Med Rep"},{"issue":"17","key":"10.1016\/j.intimp.2023.111429_b0220","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3748\/wjg.v25.i17.2019","article-title":"Microbial metabolites in non-alcoholic fatty liver disease[J]","volume":"25","author":"Zhou","year":"2019","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.intimp.2023.111429_b0225","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1530\/JOE-20-0018","article-title":"SCFAs alleviated steatosis and inflammation in mice with NASH induced by MCD[J]","volume":"245","author":"Deng","year":"2020","journal-title":"J Endocrinol"},{"key":"10.1016\/j.intimp.2023.111429_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2020.108363","article-title":"Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis[J]","volume":"81","author":"Wang","year":"2020","journal-title":"J Nutr Biochem"},{"issue":"12","key":"10.1016\/j.intimp.2023.111429_b0235","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1007\/s00253-020-10633-9","article-title":"Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation[J]","volume":"104","author":"Zhao","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"10.1016\/j.intimp.2023.111429_b0240","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.28356","article-title":"The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota[J]","volume":"63","author":"Boursier","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.intimp.2023.111429_b0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femsec\/fiu002","article-title":"Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease[J]","volume":"91","author":"Michail","year":"2015","journal-title":"FEMS Microbiol Ecol"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923017563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923017563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:07:35Z","timestamp":1761588455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923017563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":49,"alternative-id":["S1567576923017563"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111429","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111429"}}